Competitive intelligence on
small-molecule drugs and
the 80,000 global patents
covering them

Start your free trial now

No commitment — No credit card required

DrugPatentWatch Archives

You are currently viewing the 2006 archives
Click here to return to the current data set

DrugPatentWatch Premium Plan Preview

Profile for Applicant: Merck

« Back to Dashboard

Summary for Applicant: Merck

Patents:67
Tradenames:88
Ingredients:70
NDAs:108
Drug Master File Entries: (click here to view)102
Glossary
Applicant Tradename Generic Name Dosage NDA Approval Date Type RLD Patent No. Patent Expiration Exclusivity Expiration
Merck
CRIXIVAN
indinavir sulfate
CAPSULE; ORAL020685Dec 17, 1998RXNo6,645,961<disabled><disabled>
Merck
COSOPT
dorzolamide hydrochloride; timolol maleate
SOLUTION/DROPS; OPHTHALMIC020869Apr 7, 1998RXYes6,248,735<disabled><disabled>
Merck
COZAAR
losartan potassium
TABLET; ORAL020386Apr 14, 1995RXNo5,608,075*PED<disabled><disabled>
Merck
VIOXX
rofecoxib
TABLET; ORAL021042Feb 25, 2000DISCNNo<disabled><disabled>
Merck
FOSAMAX
alendronate sodium
TABLET; ORAL020560Sep 29, 1995RXNo<disabled><disabled>
This preview shows a limited data set
Subscribe for full access , or try a free trial

Export unavailable in trial.
Subscribe for complete access.

Similar Applicant Names

Individual applicants are sometimes listed under multiple names.
This search can help find similar names.

« Back to Dashboard

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors.

Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided information. There is no warranty that the information contained herein is error free. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Connect with Social Media:

Follow DrugPatentWatch on Twitter Connect with DrugPatentWatch on Linkedin Drug Patents on LinkedIn

Copyright © 2002-2014 thinkBiotech LLC. ISSN: 2162-2639

Other thinkBiotech sites: PatentStatBiotechBlogJournal of Commercial Biotechnology

`abc